Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects

Posted Monday, July 1, 2024 1:26 pm

Frank Vinluan (via MedCity News)

Eli Lilly is paying $140 million for the exclusive right to buy Radionetics Oncology for the price of $1 billion. The clinical-stage startup, a Crinetics Pharmaceuticals spinout, develops radiopharmaceuticals that target GPCRs overexpressed by solid tumors. The post Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

BioPharma, Daily, Pharma, cancer, deals, Eli Lilly, Radionetics Oncology, radiopharmaceuticals, Startups

Top stories

Hitting a Home Run for Small-Cell Lung Cancer Patients

(NewsUSA) - Not long ago, small cell lung cancer was considered the forgotten cancer, and treatment was generally chemotherapy and radiation. But now, there is a new treatment that is showing great …

Don’t Let Diabetes Shortchange Your Golden Years

(NewsUSA) - Dianne Mattiace shows that managing diabetes shouldn’t get in the way of enjoying your retirement, thanks in part to a game changing new technologyAfter a busy career in healthcare, …

Addressing Sarcopenia with a Healthy Diet

(NewsUSA) - Age-related loss of muscle mass and strength can significantly impact the quality of life for older adults. However, recent research underscores the role of proper nutrition in …

Curbing Colorectal Cancer in Minority Populations

(NewsUSA) - April is National Minority Health Month, and Black Americans, American Indians/Alaska Natives (AI/AN), and underserved Americans, are among those disproportionately affected by …

Coverage for Obesity Care is Only Fair

(NewsUSA) - Obesity is an increasingly significant health problem in the United States, especially for women. The disease affects 1 in 3 American women, including 57% of Black women and 44% of …

From the web

A boil water advisory has been issued for D.C. and Arlington over safety concerns

A water boil advisory has been issued for all of Washington D.C. and parts of Arlington., Va., officials said as the nation's capitol prepared to stage its annual Fourth of July celebrations.

GSK Pays CureVac €400M to Pick Up Clinical-Stage mRNA Vaccines for Infectious Diseases

GSK is taking over development of an avian influenza vaccine candidate as a bird flu outbreak continues in U.S. dairy cows. Meanwhile, CureVac is restructuring and returning its attention to cancer …

A new way to prevent HIV delivers dramatic results in trial

The testing of lenacapavir was halted because results were so impressive — 100% effectiveness. The decision was made to give all participants the injection rather than the alternative daily pill.

Midi Health, Keck Medicine of USC collaborate for women's care

The virtual care company will be directly available to patients experiencing menopause and perimenopause or via a Keck Medicine of USC-affiliated provider.

Foodsmart Snags $200M Investment Led By TPG’s Rise Fund

The Rise Fund will lead a $200 million investment in Foodsmart. The funding will help the telenutrition company scale its business. The post Foodsmart Snags $200M Investment Led By TPG’s Rise …